越來越多爬蟲外星人記者遇到說話問題

突破：以色列正研發癌症疫苗

Breakthrough: Israel is Developing Cancer Vaccine

: Vaxil’s groundbreaking therapeutic vaccine, developed in Israel, could keep about 90 percent of cancers from coming back.
As the world’s population lives longer than ever, if we don’t succumb to heart disease, strokes or accidents, it is more likely that cancer will get us one way or another. Cancer is tough to fight, as the body learns how to outsmart medical approaches that often kill normal cells while targeting the malignant ones.
In a breakthrough development, the Israeli company Vaxil BioTherapeutics has formulated a therapeutic cancer vaccine, now in clinical trials at Hadassah University Medical Center in Jerusalem. If all goes well, the vaccine could be available about six years down the road, to administer on a regular basis not only to help treat cancer but in order to keep the disease from recurring.
The vaccine is being tested against a type of blood cancer called multiple myeloma. If the substance works as hoped — and it looks like all arrows are pointing that way — its platform technology VaxHit could be applied to 90 percent of all known cancers, including prostate and breast cancer, solid and non-solid tumors.
“In cancer, the body knows something is not quite right but the immune system doesn’t know how to protect itself against the tumor like it does against an infection or virus. This is because cancer cells are the body’s own cells gone wrong,” says Julian Levy, the company’s CFO. “Coupled with that, a cancer patient has a depressed immune system, caused both by the illness and by the treatment.”
The trick is to activate a compromised immune system to mobilize against the threat.
A vaccine that works like a drug
A traditional vaccine helps the body’s immune system fend off foreign invaders such as bacteria or viruses, and is administered to people who have not yet had the ailment. Therapeutic vaccines, like the one Vaxil has developed, are given to sick people, and work more like a drug.
Vaxil’s lead product, ImMucin, activates the immune system by “training” T-cells –– the immune cells that protect the body by searching out and destroying cells that display a specific molecule (or marker) called MUC1. MUC1 is typically found only on cancer cells and not on healthy cells. The T-cells don’t attack any cells without MUC1, meaning there are no side effects unlike traditional cancer treatments. More than 90% of different cancers have MUC1 on their cells, which indicates the potential for this vaccine.
“It’s a really big thing,” says Levy, a biotechnology entrepreneur who was formerly CEO for Biokine Therapeutics. “If you give chemo, apart from the really nasty side effects, what often happens is that cancer becomes immune [to it]. The tumor likes to mutate and develops an ability to hide from the treatment. Our vaccines are also designed to overcome that problem.”
For cancers in an advanced stage, treatments like chemo or surgery to remove a large tumor will still be needed, but if the cancer can be brought down to scale, the body is then able to deal with it, Levy explains. ImMucin is foreseen as a long-term strategy — a shot every few months, with no side effects — to stop the cancer from reoccurring after initial treatments, by ensuring that the patient’s own immune system keeps it under control.
In parallel, the company is also working on a vaccine that treats tuberculosis, a disease that’s increasing worldwide, including in the developed world, and for which the current vaccine is often ineffective and treatment is problematic.
Based in Ness Ziona, Vaxil was founded in 2006 by Dr. Lior Carmon, a biotechnology entrepreneur with a doctorate in immunology from the Weizmann Institute of Science in Rehovot. In June, Vaxil signed a memorandum of understanding to merge its activities into Sheldonco, a company traded on the Tel Aviv Stock Exchange.
By Rivka Borochov
For more info about this incredible vaccine, visit Vaxil on the web at www.vaxilbio.com

http://unitedwithisrael.org/israel-develops-cancer-vaccine/

聲稱兩年前飛碟門前墜毀 俄婦雪櫃藏「外星人」屍體

星島日報星島日報 – 4小時前

(綜合報道)(星島日報報道)俄羅斯婦人葉戈羅夫南言之鑿鑿，指一架飛碟兩年前在其家門前墜毀，一名「外星人」死亡，她之後把外星人屍體收藏在家中雪櫃兩年。這批「外星人」照片曝光後，隨即引起網民議論紛紛。

　　葉戈羅夫南居於俄羅斯西部彼得羅扎沃茨克，她兩年前在家門外發現有不明飛行物體（UFO）墜落。她當時聽聞巨響，從家中跑出去便看到現場有着火的飛碟殘骸，旁邊躺着一具外星人屍體，她稱爆炸引發的高溫令人難以忍受。她把屍體用膠紙包裹，然後放入家中雪櫃，並拍了五張照片作為佐證，屍體一放便兩年。

　　像人魚混合體

　　這個「外星人」藏屍雪櫃的照片近日曝光，僅兩呎高，頭部特大，巨眼凸出，其中一條手臂幼如竹枝，樣子像人和魚的混合體。

　　有網民認為這個「外星人」似足《星球大戰》電影中的赫特人賈巴（Jabba The Hutt）或《捉鬼敢死隊》的為食鬼Slimmer，引起議論紛紛，也有網民揶揄這只不過是一棵腐爛的蔬菜。

　　不過，據網站Unexplained Mysteries透露，數日前有兩名男子來到葉戈羅夫南的家，他們聲稱來自俄羅斯科學院的卡里利阿研究中心，把外星人屍體充供進行調查。

　　研究超自然事件的作家科恩稱：「這可能是個精心製作的騙局，但我們不能排除出現真正的外星人，而俄羅斯已成追蹤外星人的熱點。」近日俄羅斯頻頻發生外星人「探訪」事件，例如在西伯利亞偏遠地區伊爾庫茨克，有人在八月聲稱拍攝到UFO片段，出現發光飛碟及五個外星人在雪中步行。

　　兩名學生在四月亦聲稱發現外星人屍體，並錄影作證，他們被警方盤問後，終承認是用麵包自製。
http://hk.news.yahoo.com/聲稱兩年前飛碟門前墜毀-俄婦雪櫃藏-外星人-屍體-220823832.html

清場秘密籌劃兩周 設禁飛區阻報道拘記者

明報 – 5小時前

【明報專訊】《紐約時報》引述消息稱，「佔領」大本營祖科蒂公園的清場行動，其實事前秘密籌劃兩周，紐約警方近日安排警員進行密集的人群控制及「反 恐」訓練，務求速戰速決。為防走漏風聲，在正式行動前更只有數名警隊最高層掌握實情，其他警員卻被告知只是例行演習，直至最後一刻才知要執行清場。為免清 場過程公開，警方更鐵腕封鎖傳媒，設禁飛區阻傳媒直升機追訪。
僅警高層知實情
知情人士透露，今次清場由紐約市警察局長凱利 （Raymond Kelly）親自指揮，避免重演上月胡椒噴霧對付示威者的暴力場面，令警隊形象失分。在採取行動前，當局安排警員接受兩周的密集訓練，包括在蘭德爾斯島 （Randalls Island）進行「災難演習」，以便在短時間內動員大量警力。
清場前數小時，警員還在曼哈頓東河岸作最後演練。警隊高層在最後一刻才下令到公園清場，不知就裏的警員起初還以為只是前往訓練。警方如此神秘是由於上月中的清場計劃太早曝光，觸發大量示威者湧入公園聲緩，因此今次特別選擇在公園人流最少的周二凌晨清場。
警員被告知反恐訓練
警方暗中在公園周圍擺放大光燈和擴音器，在凌晨時分突開燈並播出響亮警告，對示威者起震懾作用，很多人即時已開始收拾。多隊警員則陸續部署在公園附近，隨時增援。在場記者亦被迫離開，警方聲言是出於安全考慮，但傳媒投訴無法監察警方的行動。
其間，警方直升機更在上空盤旋，設禁飛區防範傳媒以直升機追訪，又以車輛阻擋記者視線。有記者投訴，被警方粗暴對待，或以胡椒噴霧對付，約4名記者被捕。
http://hk.news.yahoo.com/清場秘密籌劃兩周-設禁飛區阻報道拘記者-212357380.html

倫敦發通牒驅示威者

明報 – 5小時前

【明報專訊】在美國當局帶頭鐵腕打壓「佔領運動」下，強硬清場頓成全球趨勢。繼「佔領華爾街」示威被拆營帳後，倫敦警方昨亦向集結於聖保羅大教堂外的「佔領」示威者發通牒，要示威者在24小時內收拾細軟離開，否則將尋求高等法院頒令驅趕。
倫敦當局稱，聖保羅大教堂附近的商戶投訴示威影響生意，他們過去兩周與示威者談判，要求縮小佔領範圍和定下撤離日期，但示威者要求讓他們留守到元旦，「拒絕了我們的合理要求」。
瑞士澳洲強硬清場
瑞 士蘇黎世當局亦於周二早上8時驅趕駐紮於市中心林登霍夫公園（Lindenhof Park）的示威者，只給予20分鐘示威者收拾，大部分示威者收拾細軟離開，但有約30示威者和平抗爭到底，最終多人被捕。澳洲墨爾本昨亦有清場行動，警 方周三早上帶走在Treasury Garden的示威者及沒收約10個帳篷。
http://hk.news.yahoo.com/倫敦發通牒驅示威者-212325972.html